The
Costs and Benefits of Animal Experiments
*** 50% DISCOUNT
ENDS 29 FEB !!! ***
*** Read the Reviews
***
Are animal experiments justified?
A new book published by Palgrave Macmillan sheds new
light on one of the greatest controversies in animal
ethics.
Few ethical issues create as much controversy as invasive
experiments on animals. Some scientists claim they are
essential for combating major human diseases, or
detecting human toxins. Others claim the contrary, backed
by thousands of patients harmed by pharmaceuticals
developed using animal tests. Some claim all experiments
are conducted humanely, to high scientific standards.
Yet, a wealth of studies have recently revealed that
laboratory animals suffer significant stress, which may
distort experimental results.
Where, then, does the truth lie? How useful are such
experiments in advancing human healthcare? How much do
animals suffer as a result? And do students really need
to dissect or experiment on animals? What are the effects
on their attitudes towards them?
In The Costs and Benefits of Animal Experiments,
bioethicist and veterinarian Andrew Knight presents more
than a decade of ground-breaking scientific research,
analysis and experience to provide evidence-based answers
to a key question: is animal experimentation ethically
justifiable?
By analysing large numbers of animal experiments selected
randomly — the ‘gold standard’ when assessing biomedical
research, and reviewing over 500 scientific publications,
Knight is able to offer unprecedented insights into the
contributions of animal experimentation to human
healthcare, and the extent to which laboratory animals
suffer. He provides the most recent evidence-based
estimations of laboratory animal use globally and in
major world regions, and reviews the types of procedures
animals are subjected to and their level of invasiveness.
“When considering costs and benefits overall”,
he states, “one cannot reasonably conclude that the
benefits accruing to human patients or consumers, or to
those motivated by scientific curiosity or profit, exceed
the costs incurred by animals subjected to scientific
procedures. On the contrary, the evidence indicates that
actual human benefit is rarely – if ever – sufficient to
justify such costs.”
Knight concludes with an overview of key regulations
governing animal experimentation within Europe and North
America, and proposes a set of policy reforms to
facilitate increased implementation of alternative
research and testing strategies. He concludes that,
“Rigorous implementation of policies such as these
would restore to animal research the balance between
human and animal interests expected by society, intended
by legislation, and demanded by detailed ethical
review.”
CONTENTS INCLUDE:
1 - Introduction
PART I: ANIMAL COSTS
2 - Global Laboratory Animal Use
3 - Types of Laboratory Animal Use
4 - Impacts on Laboratory Animals
PART II: HUMAN BENEFITS
5 - Human Clinical Utility of Animal Models
6 - Human Toxicological Utility of Animal Models
7 - Factors Limiting the Human Utility of Animal Models
PART III: ALTERNATIVE STRATEGIES
8 - Non-Animal Research and Testing Methodologies
9 - Reduction and Refinement of Laboratory Animal Use
PART IV: EDUCATIONAL ANIMAL USE AND STUDENT
IMPACTS
10 - Educational Animal Use
11 - Effects of Harmful Animal Use on Students
PART V: CONCLUSIONS AND POLICY
RECOMMENDATIONS
12 - The Costs and Benefits of Animal Experimentation
13 - Regulatory Developments and Policy Recommendations
AUTHOR: Dr Andrew Knight, Oxford
Centre for Animal Ethics, London.
Email: info (at) animalconsultants.org.
Mobile: +44-(0)7824 376 709.
Web: www.oxfordanimalethics.com/who-we-are/fellows/.
REVIEW COPIES: Laura Conn,
Palgrave Macmillan, UK.
Email: reviews (at) palgrave.com. Phone:
+44-(0)1256 303 561.
ORDERS:
UK/World: www.palgrave.com/products/title.aspx?pid=393522.
Australasia: www.palgravemacmillan.com.au/palgrave/newonix/isbn/9780230243927.
NOTES FOR EDITORS
• In recent years laboratory animal numbers have steadily
risen globally and in many individual countries,
including the UK, US and others. The major causes are
increased use of genetically-modified animals and the
implementation of historically unprecedented large-scale
chemical testing programmes within Europe and the US.
• At the core of almost all regulations governing
laboratory animal use is the requirement that animal
ethics committees conduct a cost/benefit analysis to
ensure that the expected benefits of such research exceed
its likely costs. Humans are the major beneficiaries, and
animals incur the major costs. The required cost/benefit
analysis normally relies on educated guesses or
assumptions about human benefit and animal suffering.
However, strong scientific evidence has recently
demonstrated that these assumptions are often
fundamentally flawed. This book is the first to
comprehensively review this evidence.
• The Costs and Benefits of Animal Experiments
is the third publication in the Palgrave Macmillan Series
on Animal Ethics. The Series provides a range of key
introductory and advanced texts that map out ethical
positions on animal issues. It is expected to play a
major role in establishing the emerging field of animal
ethics. Series information: www.oxfordanimalethics.com/what-we-do/publication/animal-ethics-book-series/
and www.palgrave.com/products/Series.aspx?s=PMAES.
• The Palgrave Macmillan Series on Animal Ethics is an
initiative of the Oxford Centre for Animal Ethics
(www.OxfordAnimalEthics.com). The
latter is an international centre of excellence
dedicated to pioneering ethical perspectives on
animals through academic research, teaching, and
publication.
• Andrew Knight is an Australian bioethicist and a Fellow
of the Oxford Centre for Animal Ethics. He has published
a suite of studies examining the contribution of animal
experiments to human healthcare, which have attracted a
series of awards at international scientific conferences.
These studies also formed the basis for his 2010 PhD,
which appears to be the only one of its kind to date.
When not writing, travelling or presenting Dr Knight
practices veterinary medicine in London.